Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E19.27 EPS (ttm)1.34 Insider Own0.90% Shs Outstand34.23M Perf Week4.03%
Market Cap883.82M Forward P/E14.55 EPS next Y1.78 Insider Trans65.57% Shs Float33.93M Perf Month-11.45%
Income47.90M PEG0.80 EPS next Q0.30 Inst Own26.70% Short Float16.82% Perf Quarter-38.44%
Sales129.90M P/S6.80 EPS this Y181.00% Inst Trans0.64% Short Ratio8.96 Perf Half Y-25.95%
Book/sh2.90 P/B8.90 EPS next Y55.02% ROA56.80% Target Price52.50 Perf Year122.78%
Cash/sh1.37 P/C18.84 EPS next 5Y24.00% ROE74.10% 52W Range10.29 - 57.91 Perf YTD0.04%
Dividend- P/FCF39.81 EPS past 5Y16.10% ROI52.10% 52W High-55.42% Beta1.42
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin87.90% 52W Low151.00% ATR1.90
Employees202 Current Ratio3.70 Sales Q/Q274.80% Oper. Margin34.20% RSI (14)43.04 Volatility8.02% 6.13%
OptionableYes Debt/Eq0.00 EPS Q/Q5255.20% Profit Margin36.90% Rel Volume0.32 Prev Close26.50
ShortableYes LT Debt/Eq0.00 EarningsAug 12 BMO Payout0.00% Avg Volume636.73K Price25.82
Recom1.30 SMA20-8.94% SMA50-5.16% SMA200-21.34% Volume206,600 Change-2.57%
14-Aug-13Reiterated Oppenheimer Outperform $23 → $27
31-Jul-13Initiated Oppenheimer Outperform $23
16-Jul-14 03:40PM  6 stocks to watch at MarketWatch
11-Jul-14 06:34PM  MONDAY DEADLINE: Levi & Korsinsky, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY PR Newswire
05:02PM  Is This Marijuana Stock GW Pharmaceuticals' Biggest Risk? at Motley Fool
04:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against INSYS Therapeutics, Inc. and Certain Officers - INSY Marketwired
10-Jul-14 10:00PM  INSYS 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. - INSY Marketwired
01:58PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 Business Wire
09-Jul-14 04:10PM  Insys Completes Study on Dronabinol Oral Solution Zacks
03:55PM  Faruqi & Faruqi, LLP Reminds Investors in INSYS Therapeutics, Inc. (INSY) of Imminent Deadline to Protect Your Rights GlobeNewswire
08-Jul-14 11:36AM  INSYS Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire -5.20%
07:00AM  Insys Therapeutics Updates Timing of NDA for Dronabinol Oral Solution Marketwired
07-Jul-14 06:51PM  EQUITY ALERT: Rosen Law Firm Reminds INSYS Therapeutics Investors of Important July 2014 Class Action Deadline -- INSY Marketwired
05:42PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY Marketwired
04-Jul-14 01:17PM  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In INSYS Therapeutics, Inc. (INSY) To Contact The Firm PR Newswire
03-Jul-14 10:30AM  Insys Therapeutics' Epilepsy Therapy Gains FDA Orphan Drug Status Zacks
02-Jul-14 04:15PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY GlobeNewswire
07:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Dravet Syndrome, a Rare Form of Epilepsy Marketwired
01-Jul-14 10:32AM  INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against INSYS Therapeutics, Inc. Business Wire
04:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- INSY GlobeNewswire
30-Jun-14 01:34PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholder Of INSYS Therapeutics, Inc. Of Upcoming Deadline Business Wire
10:58AM  GW Pharma Drug Impresses At Epilepsy Conference at Investor's Business Daily
07:00AM  Insys Therapeutics Reaffirms Second Quarter 2014 Revenue Guidance Marketwired
25-Jun-14 06:09PM  Nasdaq stocks posting largest percentage increases +6.51%
01:36PM  Nasdaq stocks posting largest percentage increases
09:12AM  Wednesday's Top Health Care Stories: Aerie, Insys, and Owens & Minor at Motley Fool
09:12AM  Wednesday's Top Health Care Stories: Aerie, Insys, and Owens & Minor
08:14AM  [$$] Insys: Cannibas-Based Epilepsy Treatment Gets Orphan Drug Status at The Wall Street Journal
08:14AM  [$$] Insys: Cannibas-Based Epilepsy Treatment Gets Orphan Drug Status
07:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Rare Form of Epilepsy, Lennox-Gastaut Syndrome Marketwired
07:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Rare Form of Epilepsy, Lennox-Gastaut Syndrome
23-Jun-14 01:46PM  Shorts Are Piling Into These Stocks. Should You Be Worried?
20-Jun-14 10:30PM  EQUITY ALERT: Rosen Law Firm Reminds INSYS Therapeutics, Inc. Investors of Important Class Action Deadline -- INSY GlobeNewswire
10:30PM  EQUITY ALERT: Rosen Law Firm Reminds INSYS Therapeutics, Inc. Investors of Important Class Action Deadline -- INSY
06:04PM  Why Shorts Are Taking Aim at This Marijuana Stock at Motley Fool
06:04PM  Why Shorts Are Taking Aim at This Marijuana Stock
09:55AM  Insys Therapeutics (INSY) In A Perilous Reversal at TheStreet
09:55AM  Insys Therapeutics (INSY) In A Perilous Reversal
19-Jun-14 09:00PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged to Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire +5.30%
09:00PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged to Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
18-Jun-14 02:04PM  5 Stocks With Big Insider Buying at TheStreet
17-Jun-14 04:20PM  GW Pharma Up On Positive Data For Epilepsy Drug at Investor's Business Daily +12.29%
04:20PM  GW Pharma Up On Positive Data For Epilepsy Drug
11:59AM  GW Pharma Up On Positive Data For Epilepsy Drug at Investor's Business Daily
15-Jun-14 01:08PM  Better Marijuana Stock: GW Pharma vs Insys at Motley Fool
01:08PM  Better Marijuana Stock: GW Pharma vs Insys
13-Jun-14 11:13PM  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in INSYS Therapeutics, Inc. (INSY) to Contact the Firm Marketwired
11:13PM  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in INSYS Therapeutics, Inc. (INSY) to Contact the Firm
12:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against INSYS Therapeutics, Inc. and Certain Officers - INSY PR Newswire
12:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against INSYS Therapeutics, Inc. and Certain Officers - INSY
10-Jun-14 04:43PM  Insys Therapeutics to Present at 9th Annual JMP Securities Healthcare Conference Marketwired
04:43PM  Insys Therapeutics to Present at 9th Annual JMP Securities Healthcare Conference
10:32AM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against INSYS Therapeutics, Inc. Business Wire
10:32AM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against INSYS Therapeutics, Inc.
09-Jun-14 09:34AM  Deadline on July 14, 2014 in Lawsuit for Investors in Insys Therapeutics Inc (INSY) Shares Announced by Shareholders Foundation GlobeNewswire
06-Jun-14 03:11PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment in INSYS Therapeutics, Inc. are Encouraged to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- INSY GlobeNewswire
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
05-Jun-14 08:00AM  Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Insys Therapeutics, Inc. Business Wire
04-Jun-14 06:02PM  The 3 Biggest Biotech Crashes in May at Motley Fool
03-Jun-14 06:47AM  Why INSYS Therapeutics (INSY) Could Be Positioned for a Slump Zacks
02-Jun-14 10:39AM  Morgan & Morgan Announces That a Class Action Was Filed Against Insys Therapeutics, Inc. (INSY) GlobeNewswire
01-Jun-14 09:19AM  Insys Therapeutics: 3 Different Insiders Have Purchased Shares During The Last 30 Days at Seeking Alpha
30-May-14 02:03PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- INSY GlobeNewswire -6.17%
29-May-14 07:06AM  Insys Therapeutics submits Type II DMF to FDA for CBD API at theflyonthewall.com +5.24%
07:00AM  Insys Therapeutics Submits Drug Master File for Cannabidiol Active Pharmaceutical Ingredient (API) Marketwired
28-May-14 05:33PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged to Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
27-May-14 06:31PM  3 Biotech Stocks Falling Like a Knife: Aegerion, Insys, and Prothena at Motley Fool
10:32AM  INVESTOR ALERT: Class Action Lawsuit Against INSYS Therapeutics, Inc. Announced by Law Offices of Howard G. Smith Business Wire
23-May-14 09:09AM  BMO Capital specialty pharma analyst holds analyst/industry conference call at theflyonthewall.com
22-May-14 07:30AM  Insys Therapeutics to Present at Upcoming Conferences in June Marketwired
21-May-14 05:38PM  INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged to Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit-INSY Thomson Reuters ONE
12:18PM  INSYS THERAPEUTICS, INC. Financials EDGAR Online Financials
20-May-14 04:06PM  Lifshitz & Miller Law Firm Announces Investigation of Aeroflex Holding Corp., INSYS Therapeutics, Inc., Lihua International, Inc., Overland Storage, Inc., and The ADT Corporation PR Newswire
12:50PM  Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Insys Therapeutics, Inc. Business Wire
10:32AM  INVESTOR ALERT: Class Action Lawsuit Against INSYS Therapeutics, Inc. Filed By Glancy Binkow & Goldberg LLP Business Wire
06:27AM  Cramer's Mad Money - What Could Go Wrong With AT&T's Takeover Of DirecTV (5/19/14) at Seeking Alpha
19-May-14 07:39AM  INSYS Therapeutics (INSY) in Focus: Stock Rises 5.5% Zacks +11.32%
18-May-14 02:17PM  1 Stock Putting A New Spin on an Old Marijuana Drug at Motley Fool
16-May-14 10:00PM  INSYS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against INSYS Therapeutics, Inc. - INSY GlobeNewswire +5.53%
07:33PM  EQUITY ALERT: Rosen Law Firm Files Class Action Lawsuit Against INSYS Therapeutics, Inc. -- INSY GlobeNewswire
06:30PM  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against INSYS Therapeutics, Inc. PR Newswire
01:32PM  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Insys Therapeutics, Inc. PR Newswire
15-May-14 06:28PM  INSYS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates INSYS Therapeutics, Inc. For Investors That Have Lost Money During The Period From September 2013 to Current - INSY PR Newswire
03:48PM  Pomerantz Law Firm Announces the Filing of a Class Action Against INSYS Therapeutics, Inc. and Certain Officers -- INSY GlobeNewswire
14-May-14 02:37PM  REPEAT: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of INSYS Therapeutics, Inc. -- INSY PR Newswire -15.71%
02:25PM  Why Insys Therapeutics (INSY) Stock Is Plunging Today at TheStreet
06:03AM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
13-May-14 05:25PM  Covidien Opens Innovation Center in Turkey Zacks
04:08PM  Insys Therapeutics' (INSY) CEO Mike Babich on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
03:55PM  Insys in Focus on Subsys Worries Zacks
03:33PM  SHAREHOLDER ALERT: Investigation on Behalf of INSYS Therapeutics, Inc. Investors Announced by Law Offices of Howard G. Smith Business Wire
10:12AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
09:22AM  Tuesdays Top Health Care Stories: Halozyme, Insys, Pfizer, and AstraZeneca at Motley Fool
07:07AM  Q1 2014 Insys Therapeutics Inc Earnings Release - Before Market Open CCBN
06:52AM  Insys Therapeutics reports Q1 EPS 23c, consensus 28c at theflyonthewall.com
06:50AM  Insys Therapeutics Reports First Quarter 2014 Results Marketwired
12-May-14 10:38PM  EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Fraud Claims against INSYS Therapeutics, Inc. --- INSY Business Wire -15.45%
04:49PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of INSYS Therapeutics, Inc. - INSY PR Newswire
04:08PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
03:32PM  Insys Therapeutics issues clarifying statement on Subsys product at theflyonthewall.com
03:30PM  Insys Therapeutics Issues Clarifying Statement Marketwired
03:19PM  Notable companies reporting before tomorrow's open at theflyonthewall.com
Insys Therapeutics, Inc., a commercial-stage specialty pharmaceutical company, develops and commercializes supportive care products. It focuses on utilizing its proprietary formulation technologies to address the clinical shortcomings of existing commercial pharmaceutical products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough pain in opioid-tolerant cancer patients; and Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol. It offers its Subsys through its incentive-based commercial sales force. The company also provides Dronabinol SG Capsule, a generic equivalent to Marinol (dronabinol), an approved second-line treatment for chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. Insys Therapeutics, Inc. was incorporated in 1990 and is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KAPOOR JOHN NDirectorJun 16Buy26.135,000130,62621,174,805Jun 18 10:39 AM
KAPOOR JOHN NDirectorJun 13Buy25.445,000127,20521,169,805Jun 17 12:23 PM
KAPOOR JOHN NDirectorJun 12Buy24.8420,000496,76221,164,805Jun 16 12:57 PM
KAPOOR JOHN NDirectorJun 11Buy24.5420,000490,80021,144,805Jun 13 12:39 PM
KAPOOR JOHN NDirectorMay 19Option Exercise9.2915,991148,48215,991May 20 06:38 PM
STANLEY THEODORE HDirectorMay 19Buy24.831,00024,8306,100May 19 03:22 PM
BAKER DARRYL SChief Financial OfficerMay 15Option Exercise7.2610,00072,60014,687May 16 02:12 PM
Babich Michael LPresident and CEOMay 15Option Exercise3.257,50024,375150,562May 16 02:09 PM
STANLEY THEODORE HDirectorMay 15Buy20.983,00062,9405,100May 19 03:22 PM
FOURTEAU PATRICKDirectorMay 15Buy22.777,500170,775105,000May 15 07:42 PM
MEYER STEVEN JDirectorMay 15Buy21.385,000106,9005,000May 15 07:39 PM
Babich Michael LPresident and CEOMar 18Option Exercise2.9590,000265,72895,375Mar 18 06:54 PM
STANLEY THEODORE HDirectorMar 13Buy71.9530021,5851,400Mar 13 04:18 PM
STANLEY THEODORE HDirectorMar 12Buy73.4020014,6801,100Mar 13 04:18 PM
STANLEY THEODORE HDirectorMar 06Buy74.2620014,853900Mar 06 07:05 PM
Babich Michael LPresident and CEOMar 05Option Exercise1.84212,125390,184293,807Mar 06 07:02 PM
Dillaha LarryChief Medical OfficerMar 05Option Exercise3.18149,932476,836153,057Mar 06 07:03 PM
STANLEY THEODORE HDirectorMar 05Buy77.2920015,459700Mar 06 07:05 PM
Dillaha LarryChief Medical OfficerMar 05Sale74.57149,93211,179,7623,125Mar 06 07:03 PM
Babich Michael LPresident and CEOMar 05Sale74.58288,43221,512,1125,375Mar 06 07:02 PM